Back to search
FDAFDA · Food and drugs·Recall number D-0825-2021

Zonisamide Capsules USP 50 mg 100 Capsules Rx Only NDC 68462-129-01 Manufactured by: Glenmark Pharmaceuticals Inc., USA Monroe, NC 28110 Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430

Published September 29, 2021 · Recall initiated: August 27, 2021

Summary

FDA records drug Class II recall D-0825-2021, published September 29, 2021 and initiated August 27, 2021. Recalling firm: Glenmark Pharmaceuticals Inc., USA; Status: Terminated; Reported quantity: 15936 bottles; Lot: Lots: 29190043 Exp. 05/31/2022; 29190044 Exp. 05/31/2022; 29190045 Exp. 05/31/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations

What to do

Voluntary: Firm initiated · Letter

Get an email if ZONISAMIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ZONISAMIDE
Manufacturer
Glenmark Pharmaceuticals Inc., USA
Distributor
Nationwide.
UPC
0368462130018
Lot
Lots: 29190043 Exp. 05/31/2022; 29190044 Exp. 05/31/2022; 29190045 Exp. 05/31/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Zonisamide Capsules USP 50 mg 100 Capsules Rx Only NDC 68462-129-01 Manufactured by: Glenmark Pharmaceuticals Inc., USA Monroe, NC 28110 Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430 recalled?

Yes. FDA published recall D-0825-2021 on September 29, 2021. Reported hazard: CGMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ZONISAMIDE. UPC: 0368462130018.